Opportunity ID: 300736

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-DK-18-004
Funding Opportunity Title: Development of New Technologies and Bioengineering Solutions for the Advancement of Cell Replacement Therapies for Type 1 Diabetes (T1D) (R01 Clinical Trial Optional)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Food and Nutrition
Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.847 — Diabetes, Digestive, and Kidney Diseases Extramural Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Feb 15, 2018
Last Updated Date:
Original Closing Date for Applications: May 10, 2018
Current Closing Date for Applications: May 10, 2018
Archive Date: Jun 15, 2018
Estimated Total Program Funding: $2,500,000
Award Ceiling: $500,000
Award Floor:

Eligibility

Eligible Applicants: Independent school districts
Public and State controlled institutions of higher education
Private institutions of higher education
Special district governments
City or township governments
Native American tribal organizations (other than Federally recognized tribal governments)
Native American tribal governments (Federally recognized)
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Public housing authorities/Indian housing authorities
County governments
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Small businesses
For profit organizations other than small businesses
State governments
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Additional Information

Agency Name: National Institutes of Health
Description: This Funding Opportunity Announcement (FOA) encourages applications from institutions/organizations proposing original research addressing barriers that limit progress toward effective cell replacement therapies for type 1 diabetes (T1D). The purpose is to support research leading to the development and testing of novel and supportive technologies for the improvement of cell replacement interventions using novel biomaterials and devices for T1D treatment.
Link to Additional Information: http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-18-004.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email:FBOWebmaster@OD.NIH.GOV

Version History

Version Modification Description Updated Date

Related Documents

Packages

Agency Contact Information: NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email: FBOWebmaster@OD.NIH.GOV

Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-E Use for due dates on or after January 25, 2018 PKG00238318 Apr 10, 2018 May 10, 2018 View

Package 1

Mandatory forms

300736 RR_SF424_2_0-2.0.pdf

300736 PHS398_CoverPageSupplement_4_0-4.0.pdf

300736 RR_OtherProjectInfo_1_4-1.4.pdf

300736 PerformanceSite_2_0-2.0.pdf

300736 RR_KeyPersonExpanded_2_0-2.0.pdf

300736 PHS398_ResearchPlan_4_0-4.0.pdf

Optional forms

300736 RR_Budget_1_4-1.4.pdf

300736 RR_SubawardBudget30_1_4-1.4.pdf

300736 PHS398_ModularBudget_1_2-1.2.pdf

300736 PHS_AssignmentRequestForm_2_0-2.0.pdf

2025-07-09T10:27:38-05:00

Share This Post, Choose Your Platform!

About the Author: